9/23/2021 9:10:38 PM
Novavax Publishes Results From NanoFlu Influenza Vaccine Phase 3 Clinical Trial; Achieves All Primary Endpoints
9/23/2021 9:29:08 AM
Novavax Announces Submission To WHO For Emergency Use Listing Of Its COVID-19 Vaccine
9/8/2021 8:18:32 AM
Novavax Begins Phase 1/2 Clinical Trial Of Combination Vaccine For COVID-19 And Seasonal Influenza
8/30/2021 4:19:09 PM
Novavax Issues Statement On CDC Guidance Update For COVID-19 Clinical Trial Participants
8/25/2021 9:30:26 AM
Novavax To Evaluate Third Dose Of COVID-19 Vaccine In Participants With Impaired Immune Systems
8/16/2021 8:52:14 AM
Novavax Appoints Jim Kelly As EVP, CFO And Treasurer And Nasir Egal As SVP, Quality Assurance
8/5/2021 4:10:20 PM
Novavax Q2 Loss/share $4.75 Vs. Loss $0.30 Year Ago
8/4/2021 9:12:14 AM
Novavax : European Commission Finalizes Advance Purchase Deal For Up To 200 Mln Doses Of COVID-19 Vaccine